Arch Therapeutics, Inc.
ARTH · OTC
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6,983 | -$5,276 | -$6,240 | -$4,691 |
| Dep. & Amort. | $2 | $3 | $3 | $7 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $250 | $500 | $496 | $898 |
| Change in WC | $2,204 | $767 | -$112 | -$640 |
| Other Non-Cash | $1,153 | -$450 | -$105 | -$619 |
| Operating Cash Flow | -$3,374 | -$4,456 | -$5,959 | -$5,045 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5 | $0 | -$3 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$5 | $0 | -$3 | -$2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $995 | $3,043 | $1,050 | $726 |
| Stock Issued | $2,210 | $9 | $6,219 | $2,167 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$350 | -$106 | $0 | $933 |
| Financing Cash Flow | $2,855 | $2,936 | $7,269 | $3,826 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$524 | -$1,520 | $1,307 | -$1,221 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $747 | $2,267 | $959 | $2,180 |
| End Cash | $223 | $747 | $2,267 | $959 |
| Free Cash Flow | -$3,379 | -$4,456 | -$5,962 | -$5,047 |